NES and acute myeloid leukemia: The depletion of Nestin+ BMSCs contribute to slowing leukemia progression in primary AML mice and reducing AML cells in chimeric mice through blocking co-opt energy sources and antioxidant defense mechanisms from BMSCs [13].